Mindfulness clinical trials at UCSD
2 in progress, 1 open to eligible people
Mindfulness Engaged Neurostimulation for Depression
open to eligible people ages 18-65
Repetitive Transcranial Magnetic stimulation (rTMS) is an FDA-approved therapy for treatment resistant depression (TRD) that involves brief magnetic stimulation pulses on the dorsolateral prefrontal cortex (DLPFC) brain region. But studies of rTMS alone show remission rates of ~30%. Additionally, rTMS has not been shown to improve cognitive functioning that may be an independent factor predicting treatment success. This study will develop a novel multimodal treatment, which combines intermittent theta burst stimulation (iTBS) - a type of rTMS with digital mindfulness training to engage brain plasticity, enhance cognition and alleviate depression symptoms in individuals with TRD.
La Jolla, California
Mindfulness Based Stress Reduction for Parkinson's Disease: A Longitudinal Study
Sorry, in progress, not accepting new patients
To investigate the efficacy of Mindfulness-based Stress Reduction (MBSR),to improve HRQoL, cognition, and mood, as well as to determine the longevity of the treatment response in individuals with Parkinson's disease (PD).
San Diego, California
Our lead scientists for Mindfulness research studies include Jyoti Mishra, PhD.
Last updated: